Akèy › Kolangit Sklerozan
Etid klinik pou Kolangit Sklerozan ap rekrite nan Etazini
17 etid pou Kolangit Sklerozan ap rekrite patisipan nan sit atravè Etazini.
Vil ki gen plis etid
Pa eta
Etid ki fèk mete ajou
Tèks ofisyèl etid la (Anglè)
Unraveling the Mechanisms Underlying Primary Sclerosing Cholangitis Through a Multidisciplinary, Integrative Research Approach
Ap rekriteEtid obsèvasyonVolontè an sante akeyi
Laj 18 a 90 · Tout sèks · Mizajou Sep 22, 2026 · NCT04685200A Study to Assess How Well and Safely Elafibranor Works in Adult Participants With Primary Sclerosing Cholangitis
Ap rekriteFaz 3
Laj 18 a 75 · Tout sèks · Mizajou Aug 31, 2026 · NCT07387549A-LiNK: Improving Outcomes in Autoimmune Liver Disease
Ap rekriteEtid obsèvasyon
Tout laj · Tout sèks · Mizajou Aug 19, 2026 · NCT05750498MRI Based Biomarkers in Pediatric Autoimmune Liver Disease
Ap rekriteEtid obsèvasyon
Laj 6 a 23 · Tout sèks · Mizajou Aug 19, 2026 · NCT03175471MRI Biomarkers in as Predictor of Clinical Endpoints in Pediatric Autoimmune Liver Disease
Ap rekriteEtid obsèvasyon
Laj 6 a 23 · Tout sèks · Mizajou Aug 19, 2026 · NCT03178630Detoxification of the Liver In PSC (Dolphin)
Ap rekriteFaz 2
Laj 18 a 75 · Tout sèks · Mizajou Jul 21, 2026 · NCT05835505Pharmacologic Approaches to Preventing Primary Sclerosing Cholangitis Recurrence After Liver Transplantation
Ap rekriteFaz 2
Laj 18 a 75 · Tout sèks · Mizajou Jul 17, 2026 · NCT06905054Primary Sclerosing Cholangitis in Children
Ap rekriteEtid obsèvasyon
Laj 2 a 25 · Tout sèks · Mizajou Jul 14, 2026 · NCT04181138Evaluation of an Oral Microbiota-based Therapeutic as a Treatment Option for PSC
Ap rekriteFaz 1 bonè
Laj 18 a 76 · Tout sèks · Mizajou May 20, 2026 · NCT06197308A Study of TAK-781 in Healthy Volunteers and in Participants With Non-Cirrhotic Primary Sclerosing Cholangitis (PSC)
Ap rekriteFaz 1Volontè an sante akeyi
Laj 18 a 68 · Tout sèks · Mizajou Mar 5, 2026 · NCT07229911Statin Therapy in Primary Sclerosing Cholangitis (PSC): a Multi-omics Study
Ap rekriteFaz 1 bonèVolontè an sante akeyi
Laj 18 a 80 · Tout sèks · Mizajou Feb 27, 2026 · NCT05912387Characterization of Biliary Cell-derived Organoids From Bile of PSC and Non-PSC Patients
Ap rekriteEtid obsèvasyonVolontè an sante akeyi
Laj 18 a 85 · Tout sèks · Mizajou Feb 17, 2026 · NCT04753996Biobank for Cholestatic Liver Diseases.
Ap rekriteEtid obsèvasyonVolontè an sante akeyi
Laj 18 a 85 · Tout sèks · Mizajou Feb 17, 2026 · NCT03445585A Study of SIPLIZUMAB in AILD and LT Patients
Ap rekriteFaz 1
Laj 18 ak plis · Tout sèks · Mizajou Nov 24, 2025 · NCT06455280A Study to Assess the Safety and Efficacy of LB-P8 in Patients With PSC
Ap rekriteFaz 2
Laj 18 a 75 · Tout sèks · Mizajou Oct 24, 2025 · NCT06699121Oral Hymecromone to Treat Adolescents and Adults With Primary Sclerosing Cholangitis.
Ap rekriteFaz 2
Laj 14 a 75 · Tout sèks · Mizajou Jun 13, 2025 · NCT05295680Treating Primary Sclerosing Cholangitis and Biliary Atresia With Vancomycin
Ap rekriteFaz 1Volontè an sante akeyi
2 Weeks – 40 Years · Tout sèks · Mizajou Nov 15, 2016 · NCT02137668Sous ClinicalTrials.gov, done yo ranmase Oct 1, 2026. Chak etid gen kritè li pou li menm; ekip etid la deside ki moun ki ka patisipe.